| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.0008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |